Jinhe Biology: Jinhe Holdings plans to reduce its stake in the company by no more than 3%.

On May 16, Jinhe Biology announced that the controlling shareholder Jinhe Holdings plans to reduce its holdings of the company's shares by no more than 22,563,400 shares, that is, no more than 3% of the company's total share capital, through centralized bidding transactions and block transactions from June 10, 2025 to September 9, 2025. Among them, no more than 7,521,100 shares were reduced through centralized bidding, accounting for 1% of the total share capital; No more than 15,042,300 shares were reduced through block trading, accounting for 2% of the total share capital. The reason for the reduction is to repay the pledged debt, and the price of the reduction will be determined according to the market price.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • 2
  • Repost
  • Share
Comment
0/400
Klb257vip
· 05-16 13:24
Can I buy in?
View OriginalReply0
RippleFlyvip
· 05-16 12:51
Ape In 🚀
Reply1
Trade Crypto Anywhere Anytime
qrCode
Scan to download Gate App
Community
English
  • 简体中文
  • English
  • Tiếng Việt
  • 繁體中文
  • Español
  • Русский
  • Français (Afrique)
  • Português (Portugal)
  • Bahasa Indonesia
  • 日本語
  • بالعربية
  • Українська
  • Português (Brasil)